Skip main navigation
Fluorescent Imaging immunofluorescence of cancer cells growing in 2D with nuclei in blue, cytoplasm in red and DNA damage foci in green

REPROCELL Bioserve™

Diagnostic Services

Under the guidance of a quality control (QC) manager and supervising physician, our clinical laboratory technicians have worked with over 300 medical institutions throughout Japan and many hundreds more in the USA, India, and Europe. Our screening tests offer superior accuracy and efficacy compared to standard methods of diagnosis.

Accelerating breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics

Our Diagnostic Services

HLA Typing and Crossmatching

As experts in human tissue research, we offer a comprehensive range of diagnostic tests that can screen for the presence of donor-specific antibodies (DSA) before or after transplantation. We use up to four different diagnostic tests in our HLA typing service:

  • Flowcytometric crossmatching (FCXM)
  • Anti-HLA antibody screening and single antigen identification (Class I & II)
  • HLA typing

  Learn more about our HLA Typing & crossmatching services

COVID PCR Testing

In 2021 we launched a high throughput Covid-19 identification service to contribute to the end of the pandemic. This PCR-based method uses SmartAmp and Allplex screening to identify coronavirus variants. The Allplex system can simultaneously detect:

  • HV69/70 del mutation found in the UK variant
  • E484K found in the South African and Brazilian variants
  • N501Y found in all three novel variants

  Read the official Press Release

PreciONC Oncology

Bioserve India

Our pharmacogenomics assays can help clinicians to make better decisions about treatment choices and prescribing. These integrated molecular diagnostic solutions can assist at every stage of the cancer journey:

  • Hereditary risk assessment
  • Diagnosis and Prognosis
  • Treatment selection and monitoring
  • Disease surveillance

  Explore oncology services on the Bioserve India website